A Global CRO Delivering Medicines the World Can Trust

Established in 1997, Ergomed is a global leader in delivering specialized services in oncology, rare disease, and complex trials to the pharmaceutical and biotech sectors. Our comprehensive support covers the entire clinical trial process, from early phase to post-approval, offering full-service, industry-leading clinical trial management solutions as a trusted partner. Our integrated service model helps life sciences companies meet regulatory obligations, maximize drug development success, and enhance the patient experience.

A Legacy of Patient-Centric Care

At Ergomed, our patient-centric approach is not just a strategy; it’s a legacy. Inspired by the vision of our founder, Dr. Miroslav Reljanović, we believe in the transformative potential of clinical research to improve patients’ lives. Dr. Reljanović, a dedicated medical doctor and board-certified neurologist, is the driving force behind Ergomed. His passion and unwavering commitment to clinical research have underpinned the success of countless clinical development programs. Our legacy of caregiving is evident in our focus on the patient experience, our support of study coordinators at investigator sites, and our medic-to-medic engagement to underpin principal investigator success.

Our History

Pioneering Success Across the Drug Development Spectrum

Since our inception, Ergomed has been a steadfast partner in the pharmaceutical industry, delivering solutions across the entire drug development lifecycle, from proof-of-concept to late-stage programs. Our success in managing over 600 phase I-IV clinical trials is a testament to our comprehensive capabilities. We dedicate significant patient, clinician, and data resources to inform trial design and operationally deliver with a bias to action. Our global capacity and proven scientific and regulatory expertise empower us to drive maximum speed and confidence to market. Our legacy of co-development has cemented our unwavering commitment to sponsor success.

Globally Recognized Leader in Clinical Research

As a globally recognized leader in the pharmaceutical and biotech sectors, Ergomed leverages its significant footprint to deliver exceptional results. Our deep bench of hundreds of MDs and Ph.D.s use their scientific expertise to support the trial’s success at every stage of its execution. With our U.S. hubs in Boston and Raleigh, our manifold offices across Western/Central/Eastern Europe, and our teams in East and South Asia, our comprehensive approach ensures that we remain a trusted partner for life sciences companies. Ergomed provides the expertise in oncology, rare diseases, and complex trials necessary to enhance the patient experience and bring life-changing medicines to market swiftly and efficiently.

Our Offices & Clinical Research Areas
  • Clinical Research
  • Office Location

Patient-Focused, Ergo, Better Trials

Contact Us

Our Complementary Services

See how Ergomed can support your clinical trial.

More Ergomed Services

Find out how Ergomed supports your clinical trial objectives.